Journal of Drug Assessment, Volume 7, Issue sup1 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Drug Assessment, Volume 7, Issue sup1 (2018)

See all volumes and issues
Vol 12, 2023 Vol 11, 2022 Vol 10, 2021 Vol 9, 2020 Vol 8, 2019 Volume 7, 2018 Vol 6, 2017 Vol 5, 2016 Vol 4, 2015 Vol 3, 2014 Vol 2, 2013 Vol 1, 2012
Download citations Download PDFs Download issue

National Association of Specialty Pharmacy (NASP) Annual Meeting Abstracts

Introduction

Introduction
The National Association of Specialty Pharmacy Abstract Program
R. A. Brook & S. Arquette
Page: 1
Published online: 20 Sep 2018
CitationforThe National Association of Specialty Pharmacy Abstract Program | Full Text | PDF (138.7 KB)
  • 532 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #1

Abstract
Evaluation of the impact of sequential learning of pharmacy continuing education on idiopathic pulmonary fibrosis
D. Desai, O. Mills, C. Schneider & J. Palatine
Page: 2
Published online: 20 Sep 2018
AbstractforEvaluation of the impact of sequential learning of pharmacy continuing education on idiopathic pulmonary fibrosis | Full Text | PDF (168.1 KB)
  • 467 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #2

Abstract
Clinical and economic impact of a comprehensive specialty pharmacy oral oncology patient management program
A. Saulles & J. Chang
Page: 3
Published online: 20 Sep 2018
AbstractforClinical and economic impact of a comprehensive specialty pharmacy oral oncology patient management program | Full Text | PDF (167.7 KB)
  • 754 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #3

Abstract
Assessing the impact of specialty pharmacy interventions in obtaining sustained viral response (SVR) labs in Hepatitis C patients, in an urban, underserved population
A. Cowden, M. Tran & A. Dietzek
Page: 4
Published online: 20 Sep 2018
AbstractforAssessing the impact of specialty pharmacy interventions in obtaining sustained viral response (SVR) labs in Hepatitis C patients, in an urban, underserved population | Full Text | PDF (169.1 KB)
  • 470 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #4

Abstract
Case study: improvement in amyotrophic lateral sclerosis symptoms in a patient receiving edaravone infusions
B. Prosser, C. Miller & K. Malloy
Page: 5
Published online: 20 Sep 2018
AbstractforCase study: improvement in amyotrophic lateral sclerosis symptoms in a patient receiving edaravone infusions | Full Text | PDF (167.7 KB)
  • 601 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #5

Abstract
Using rates of non-adherence to identify opportunities for intervention in outpatient specialty clinics
E. Cherry, J. Jolly & A. D. Zuckerman
Page: 6
Published online: 20 Sep 2018
AbstractforUsing rates of non-adherence to identify opportunities for intervention in outpatient specialty clinics | Full Text | PDF (167.5 KB)
  • 479 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #6

Abstract
Impact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy
M. Chinn, V. Reynolds, J. Jolly & A. D. Zuckerman
Page: 7
Published online: 20 Sep 2018
AbstractforImpact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy | Full Text | PDF (169.3 KB)
  • 471 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #7

Abstract
ESC/EAS clinical guidance recommendations: impact on patient eligibility for PCSK9 inhibitor therapy
G. Schardt, M. Wolfe, K. Nolan, J. Murray & D. Hilleman
Page: 8
Published online: 20 Sep 2018
AbstractforESC/EAS clinical guidance recommendations: impact on patient eligibility for PCSK9 inhibitor therapy | Full Text | PDF (168.6 KB)
  • 1375 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #8

Abstract
Impact of a dedicated medication access coordinator on PCSK9 inhibitor approval rates
M. Wolfe, D. Hilleman, K. Nolan & G. Schardt
Page: 9
Published online: 20 Sep 2018
AbstractforImpact of a dedicated medication access coordinator on PCSK9 inhibitor approval rates | Full Text | PDF (169.2 KB)
  • 407 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #9

Abstract
The impact of clinical pharmacist in asthma care at specialty pharmacy
C. Williams & A. Strachan
Page: 10
Published online: 20 Sep 2018
AbstractforThe impact of clinical pharmacist in asthma care at specialty pharmacy | Full Text | PDF (167.7 KB)
  • 648 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #10

Abstract
Impact of specialty pharmacy taking ownership of the prior authorization process of multiple sclerosis specialty medications to increase access todisease-modifying therapy
J. Kidd, M. Carraro, K. Essick, E. Johnson & J. Reichard
Page: 11
Published online: 20 Sep 2018
AbstractforImpact of specialty pharmacy taking ownership of the prior authorization process of multiple sclerosis specialty medications to increase access todisease-modifying therapy | Full Text | PDF (167.6 KB)
  • 465 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #11

Abstract
An evaluation of a local oncology specialized pharmacists’ training program in non-small cell lung cancer
E. A. Witt, E. Shafer, F. Staskon & J. Powers
Page: 12
Published online: 20 Sep 2018
AbstractforAn evaluation of a local oncology specialized pharmacists’ training program in non-small cell lung cancer | Full Text | PDF (167.9 KB)
  • 441 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #12

Abstract
Patient experiences with FVIII products: differences in wastage, vial numbers and preparation time
J. Setyawan, M. H. Erder & M. Fridman
Page: 13
Published online: 20 Sep 2018
AbstractforPatient experiences with FVIII products: differences in wastage, vial numbers and preparation time | Full Text | PDF (169.4 KB)
  • 432 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #15

Abstract
Evaluating possible use of IVIG in autism spectrum disorder (ASD)
M. O. Fadeyi & T. K. Li
Page: 14
Published online: 20 Sep 2018
AbstractforEvaluating possible use of IVIG in autism spectrum disorder (ASD) | Full Text | PDF (167.4 KB)
  • 1255 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #16

Abstract
Recombinant human C1-esterase inhibitor for the prevention of acute hereditary angioedema attacks: a case report
A. B. Vegh, N. Park & T. Cantwell
Page: 15
Published online: 20 Sep 2018
AbstractforRecombinant human C1-esterase inhibitor for the prevention of acute hereditary angioedema attacks: a case report | Full Text | PDF (167.9 KB)
  • 1039 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #17

Abstract
2018 cancer concerns of United States health plans
R. A. Brook & J. E. Smeeding
Page: 16
Published online: 20 Sep 2018
Abstractfor2018 cancer concerns of United States health plans | Full Text | PDF (168.8 KB)
  • 401 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #18

Abstract
Management of specialty pharmacies, specialty and biosimilar products
R. A. Brook & J. E. Smeeding
Page: 17
Published online: 20 Sep 2018
AbstractforManagement of specialty pharmacies, specialty and biosimilar products | Full Text | PDF (169.6 KB)
  • 485 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #19

Abstract
Impact of two-way texting for refill reminders and refill set-up on a phenylketonuria (PKU) patient population
M. Snyder, B. Sager, S. Ill, N. Lachner, D. Allen, J. Peterson & H. Budlong
Page: 18
Published online: 20 Sep 2018
AbstractforImpact of two-way texting for refill reminders and refill set-up on a phenylketonuria (PKU) patient population | Full Text | PDF (169.1 KB)
  • 367 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #20

Abstract
Ensuring continuity of care for patients transitioning from intravenous to subcutaneous therapy at a health system owned specialty pharmacy
J. Peterson, H. Budlong, B. Tisthammer, T. Paine, A. McNamara & D. Simonson
Page: 19
Published online: 20 Sep 2018
AbstractforEnsuring continuity of care for patients transitioning from intravenous to subcutaneous therapy at a health system owned specialty pharmacy | Full Text | PDF (167.7 KB)
  • 526 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #21

Abstract
Impact of comprehensive pharmacy services on patient centered outcomes in a hematology and oncology clinic
R. Swisher, A. Feldman & N. Kasbekar
Page: 20
Published online: 20 Sep 2018
AbstractforImpact of comprehensive pharmacy services on patient centered outcomes in a hematology and oncology clinic | Full Text | PDF (167.9 KB)
  • 626 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #22

Abstract
Specialty pharmacy patient and provider engagement improveshepatitis C outcomes
A. McNamara, H. Budlong, J. Peterson & B. Tisthammer
Page: 21
Published online: 20 Sep 2018
AbstractforSpecialty pharmacy patient and provider engagement improveshepatitis C outcomes | Full Text | PDF (168.5 KB)
  • 448 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #23

Abstract
Impact of specialty pharmacist involvement on patient access to PCSK9 inhibitors
N. Lawson, K. Beeker & D. Cruse
Page: 22
Published online: 20 Sep 2018
AbstractforImpact of specialty pharmacist involvement on patient access to PCSK9 inhibitors | Full Text | PDF (169 KB)
  • 437 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #24

Abstract
Retrospective analysis studying clinical outcomes in psoriasis patients who switched from a biologic medication to either secukinumab or ixekizumab
J. Robertson, P. Koerner, F. Staskon, R. Miller & R. Baiano
Page: 23
Published online: 20 Sep 2018
AbstractforRetrospective analysis studying clinical outcomes in psoriasis patients who switched from a biologic medication to either secukinumab or ixekizumab | Full Text | PDF (168.9 KB)
  • 455 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Poster #25

Abstract
Digital refill reminders, adherence and length of therapy amongHIV pre-exposure prophylaxis medication users
R. Hazen, H. Kirkham, J. Hou, G. Pietrandoni & A. Delpino
Page: 24
Published online: 20 Sep 2018
AbstractforDigital refill reminders, adherence and length of therapy amongHIV pre-exposure prophylaxis medication users | Full Text | PDF (169.2 KB)
  • 407 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #26

Abstract
Effect of patient- and drug-specific barcode technology on medication dispensing errors in a specialty pharmacy
B. Feinberg, R. Burruss, A. Wood, V. Arikian, R. Jaster, K. Oleru, T. Traurig, B. Sutherland, C. Nabhan & A. Klink
Pages: 25-26
Published online: 20 Sep 2018
AbstractforEffect of patient- and drug-specific barcode technology on medication dispensing errors in a specialty pharmacy | Full Text | References | PDF (227.9 KB)
  • 1181 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #27

Abstract
Creating a consistent pathway to deliver clinical information to the patient by embedding key resources into a home-grown specialty pharmacy patient management platform
M. Snell, A. Delgado, I. Kashat, S. Patel, T. Kocevski & J. Van Lare
Page: 27
Published online: 20 Sep 2018
AbstractforCreating a consistent pathway to deliver clinical information to the patient by embedding key resources into a home-grown specialty pharmacy patient management platform | Full Text | PDF (168.3 KB)
  • 399 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Poster #28

Abstract
Technology-enabled specialty pharmacy utilization of the routine assessment of patient index data 3 (RAPID3) to monitor and enhance outcomes of rheumatoid arthritis (RA) patients – a retrospective review
K. Tran & L. Duong
Page: 28
Published online: 20 Sep 2018
AbstractforTechnology-enabled specialty pharmacy utilization of the routine assessment of patient index data 3 (RAPID3) to monitor and enhance outcomes of rheumatoid arthritis (RA) patients – a retrospective review | Full Text | PDF (169.8 KB)
  • 661 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Explore articles